PubMed

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, Rouzioux C, Autran B, Katlama C, Carcelain G; ALT-ANRS CO-15 study group; DECAMUNE study group.

AIDS. 2009 Nov 26. [Epub ahead of print]PMID: 19952710 [PubMed - as supplied by publisher]Related articles

Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?

Kousignian I, Launay O, Mayaud C, Rabaud C, Costagliola D, Abgrall S; on behalf of the FHDH-ANRS CO4.

J Antimicrob Chemother. 2009 Nov 10. [Epub ahead of print]PMID: 19903719 [PubMed - as supplied by publisher]Related articles

Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.

Ayouba A, Lien TT, Nouhin J, Vergne L, Aghokeng AF, Ngo-Giang-Huong N, Diop H, Kane CT, Valéa D, Rouet F, Joulia-Ekaza D, Toni TD, Nerrienet E, Ngole EM, Delaporte E, Costagliola D, Peeters M, Chaix ML.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1193-6.PMID: 19886834 [PubMed - in process]Related articles

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.

Assoumou L, Cozzi-Lepri A, Brun-Vézinet F, Degruttola V, Kuritzkes DR, Phillips A, Zolopa A, Miller V, Flandre P, Costagliola D; on behalf of the Standardization, Clinical Relevance of HIV Drug Resistance Testing Project from the Forum for Collaborative HIV Research.

AIDS. 2009 Oct 27. [Epub ahead of print]PMID: 19864933 [PubMed - as supplied by publisher]Related articles

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Lièvre M; Members of Epidemiology Working Group of French Pharmacovigilance Commission, Costagliola D, Evans S, Fourrier A, Imbs JL, Levy-Bruhl D, Merle L, Micallef J, Oger E.

Neurology. 2009 Oct 27;73(17):1426-7. No abstract available. PMID: 19858469 [PubMed - in process]Related articles

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.

Aslangul E, Assoumou L, Bittar R, Valantin MA, Kalmykova O, Peytavin G, Fiévet MH, Boccara F, Bonnefont-Rousselot D, Melchior JC, Giral P, Costagliola D.

AIDS. 2010 Jan 2;24(1):77-83.PMID: 19838098 [PubMed - in process]Related articles

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D; Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort.

Lancet Oncol. 2009 Dec;10(12):1152-9. Epub 2009 Oct 7.PMID: 19818686 [PubMed - in process]Related articles

Skin cancers associated with HIV infection and solid organ transplant among elderly adults.

Lanoy E, Costagliola D, Engels EA.

Int J Cancer. 2009 Oct 6. [Epub ahead of print]PMID: 19810102 [PubMed - as supplied by publisher]Related articles

Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalite 2000 & 2005' Surveys (ANRS EN19).

Hessamfar-Bonarek M, Morlat P, Salmon D, Cacoub P, May T, Bonnet F, Rosenthal E, Costagliola D, Lewden C, Chêne G; the Mortalité 2000 & 2005 Study Groups.

Int J Epidemiol. 2009 Oct 5. [Epub ahead of print]PMID: 19805489 [PubMed - as supplied by publisher]Related articles

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

antiretroviral therapy cohort collaboration (ART-CC), Lanoy E, May M, Mocroft A, Phillip A, Justice A, Chêne G, Furrer H, Sterling T, Monforte AD, Force L, Gill J, Harris R, Hogg RS, Rockstroh J, Saag M, Khaykin P, de Wolf F, Sterne JA, Costagliola D.

AIDS. 2009 Oct 23;23(16):2199-208.PMID: 19779320 [PubMed - in process]Related articles

[Towards a vaccine for HIV infection: role of the gp41 envelope protein]

Debre P, Costagliola D, Legrand R, Vieillard V.

Bull Acad Natl Med. 2009 Jan;193(1):127-36; discussion 137-8. French. PMID: 19718985 [PubMed - indexed for MEDLINE]Related articles

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

Moore DM, Harris R, Lima V, Hogg B, May M, Yip B, Justice A, Mocroft A, Reiss P, Lampe F, Chêne G, Costagliola D, Elzi L, Mugavero MJ, Monforte AD, Sabin C, Podzamczer D, Fätkenheuer G, Staszewski S, Gill J, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):357-63.PMID: 19668084 [PubMed - indexed for MEDLINE]Related articles

Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.

Mouala C, Guiguet M, Houzé S, Damond F, Pialoux G, Viget N, Costagliola D, Le Bras J, Matheron S; FHDH-ANRS CO4 Clinical Epidemiology Group.

AIDS. 2009 Sep 24;23(15):1997-2004.PMID: 19654499 [PubMed - in process]Related articles

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

Marin B, Thiébaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, Hamouda O, Prins M, Walker S, Porter K, Sabin C, Chêne G.

AIDS. 2009 Aug 24;23(13):1743-53.PMID: 19571723 [PubMed - in process]Related articles

Trends in post-infection CD4 cell counts and plasma HIV-1 RNA levels in HIV-1-infected patients in France between 1997 and 2005.

Potard V, Weiss L, Lamontagne F, Rouveix E, Beck-Wirth G, Drogoul-Vey MP, Souala MF, Costagliola D; French Hospital Database on HIV ANRS CO4.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):422-6.PMID: 19521249 [PubMed - indexed for MEDLINE]Related articles

A step ahead on the HIV collaboratory.

Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ, Papagno L, Schacker TW, Wain-Hobson S, Walker BD, Youle M.

Science. 2009 Jun 5;324(5932):1264-5. No abstract available. PMID: 19498149 [PubMed - indexed for MEDLINE]Related articles

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.

Soulié C, Assoumou L, Ghosn J, Duvivier C, Peytavin G, Ait-Arkoub Z, Molina JM, Costagliola D, Katlama C, Calvez V, Marcelin AG.

AIDS. 2009 Jul 31;23(12):1605-8.PMID: 19487903 [PubMed - indexed for MEDLINE]Related articles

CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3.

Guiguet M, Kendjo E, Carcelain G, Abgrall S, Mary-Krause M, Tattevin P, Yazdanpanah Y, Costagliola D, Duval X; FHDH-ANRS CO4 Epidemiology Group.

Antivir Ther. 2009;14(3):451-7.PMID: 19474479 [PubMed - indexed for MEDLINE]Related articles

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, Macrae E, Maljkovic-Berry I, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen MO, Schmit JC, Schuurman R, Soriano V, Stanczak J, Stanojevic M, Struck D, Van Laethem K, Violin M, Yerly S, Zazzi M, Boucher CA, Vandamme AM; SPREAD Programme.

Retrovirology. 2009 May 20;6:49.PMID: 19457244 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.

Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D.

AIDS. 2009 Jun 1;23(9):1163-9.PMID: 19444075 [PubMed - indexed for MEDLINE]Related articles

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D; ANRS 121 Hippocampe study group.

AIDS. 2009 Apr 27;23(7):817-24.PMID: 19363330 [PubMed - indexed for MEDLINE]Related articles

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR.

Lancet. 2009 Apr 18;373(9672):1352-63. Epub 2009 Apr 8. Review.PMID: 19361855 [PubMed - indexed for MEDLINE]Related articlesFree article

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.

Chaix ML, Descamps D, Wirden M, Bocket L, Delaugerre C, Tamalet C, Schneider V, Izopet J, Masquelier B, Rouzioux C, Meyer L, Costagliola D; ANRS AC11 Resistance Group; Cohort PRIMO ANRS CO 6; FHDH ANRS CO4 Study Groups.

AIDS. 2009 Mar 27;23(6):717-24.PMID: 19279445 [PubMed - in process]Related articles

Environmental genomics: a tale of two fishes.

Bucciarelli G, Di Filippo M, Costagliola D, Alvarez-Valin F, Bernardi G, Bernardi G.

Mol Biol Evol. 2009 Jun;26(6):1235-43. Epub 2009 Mar 6.PMID: 19270014 [PubMed - indexed for MEDLINE]Related articles

Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.

Salmon-Ceron D, Rosenthal E, Lewden C, Bouteloup V, May T, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Cacoub P, Chêne G; ANRS EN19 Mortalité Study Group and Mortavic.

J Hepatol. 2009 Apr;50(4):736-45. Epub 2009 Jan 3.PMID: 19231018 [PubMed - indexed for MEDLINE]Related articles

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

Rosenthal E, Salmon-Céron D, Lewden C, Bouteloup V, Pialoux G, Bonnet F, Karmochkine M, May T, François M, Burty C, Jougla E, Costagliola D, Morlat P, Chêne G, Cacoub P; Mortavic/Mortalité 2005 Study Group.

HIV Med. 2009 May;10(5):282-9. Epub 2009 Feb 15.PMID: 19226410 [PubMed - in process]Related articles

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, Chêne G, Morlat P; Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group; Mortavic Study Group.

Clin Infect Dis. 2009 Mar 1;48(5):633-9.PMID: 19202627 [PubMed - indexed for MEDLINE]Related articles

How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates.

Lanoy E, Lewden C, Lièvre L, Tattevin P, Boileau J, Aouba A, Chêne G, Costagliola D; Clinical Epidemiologic Group of the French Hospital Database on HIV (ANRS CO4 FHDH); Groupe d'Etude Mortalité 2000.

HIV Med. 2009 Apr;10(4):236-45. Epub 2008 Jan 28.PMID: 19178591 [PubMed - in process]Related articles

Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.

Fontas E, Kousignian I, Pradier C, Duvivier C, Poizot-Martin I, Durier C, Jarrousse B, Weiss L, Levy Y, Costagliola D; FHDH ANRS CO4 ANRS CO141.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):206-14.PMID: 19131886 [PubMed - indexed for MEDLINE]Related articles

Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice.

Mounier N, Katlama C, Costagliola D, Chichmanian RM, Spano JP.

Crit Rev Oncol Hematol. 2009 Oct;72(1):10-20. Epub 2008 Dec 12. Review.PMID: 19070506 [PubMed - indexed for MEDLINE]Related articles

[A fighting life against AIDS]

Costagliola D.

Med Sci (Paris). 2008 Nov;24(11):979-80. French. No abstract available. PMID: 19038103 [PubMed - indexed for MEDLINE]Related articles

[Cervical cancer: new testing strategies?]

Heard I, Costagliola D.

Med Sci (Paris). 2008 Nov;24(11):977-8. French. No abstract available. PMID: 19038102 [PubMed - indexed for MEDLINE]Related articles

Observation plans in longitudinal studies with time-varying treatments.

Hernán MA, McAdams M, McGrath N, Lanoy E, Costagliola D.

Stat Methods Med Res. 2009 Feb;18(1):27-52. Epub 2008 Nov 26. No abstract available. PMID: 19036915 [PubMed - indexed for MEDLINE]Related articles

Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.

Martinez V, Diemert MC, Braibant M, Potard V, Charuel JL, Barin F, Costagliola D, Caumes E, Clauvel JP, Autran B, Musset L; ALT ANRS CO15 Study Group.

Clin Infect Dis. 2009 Jan 1;48(1):123-32.PMID: 19035778 [PubMed - indexed for MEDLINE]Related articles

[Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!]

Costagliola D.

Rev Epidemiol Sante Publique. 2008 Dec;56(6):379-81. Epub 2008 Nov 18. French. No abstract available. PMID: 19019601 [PubMed - indexed for MEDLINE]Related articles

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Antiretroviral Therapy Cohort Collaboration (ART-CC), Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A, Lampe F, Miró JM, Staszewski S, Sterne JA.

AIDS. 2008 Nov 30;22(18):2481-92.PMID: 19005271 [PubMed - indexed for MEDLINE]Related articles

[Epidemiology of HIV infection in France and Europe]

Costagliola D.

Rev Med Interne. 2008 Dec;29 Suppl 3:S266-8. Epub 2008 Nov 8. French. No abstract available. PMID: 18996629 [PubMed - indexed for MEDLINE]Related articles

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART).

Guiguet M, Porter K, Phillips A, Costagliola D, Babiker A.

Open AIDS J. 2008;2:3-9. Epub 2008 Feb 12.PMID: 18923700 [PubMed - in process]Related articlesFree article

One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?

Costagliola D, Damond F, Palmer P, Rouzioux C, Brun-Vezinet F.

AIDS. 2008 Oct 1;22(15):2042-4.PMID: 18784468 [PubMed - indexed for MEDLINE]Related articles

Surgical management of cervical intraepithelial neoplasia in HIV-infected women.

Foulot H, Heard I, Potard V, Costagliola D, Chapron C.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):153-7. Epub 2008 Aug 28.PMID: 18760524 [PubMed - indexed for MEDLINE]Related articles

Increased cardiovascular risk in HIV infection: drugs, virus and immunity.

Murphy R, Costagliola D.

AIDS. 2008 Aug 20;22(13):1625-7. No abstract available. PMID: 18670222 [PubMed - indexed for MEDLINE]Related articles

Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study.

Mouala C, Houzé S, Guiguet M, Abboud P, Pialoux G, Viget N, Costagliola D, Matheron S.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):55-60.PMID: 18667929 [PubMed - indexed for MEDLINE]Related articles

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Salmon D, Cacoub P, Chêne G; ANRS EN19 Mortalité Study Group and Mortavic1.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8.PMID: 18645512 [PubMed - indexed for MEDLINE]Related articles

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.

Duvivier C, Ghosn J, Assoumou L, Soulié C, Peytavin G, Calvez V, Génin MA, Molina JM, Bouchaud O, Katlama C, Costagliola D; ANRS 121 study group.

J Antimicrob Chemother. 2008 Oct;62(4):797-808. Epub 2008 Jul 18.PMID: 18641035 [PubMed - indexed for MEDLINE]Related articlesFree article

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.

Valantin MA, Lanoy E, Bentata M, Kalmykova O, Boutekadjirt A, Allavena C, Rozenbaum W, Peytavin G, Amellal B, Calvez V, Costagliola D, Katlama C; NoNuke ANRS 108 Study Team.

HIV Med. 2008 Oct;9(8):625-35. Epub 2008 Jul 8.PMID: 18624724 [PubMed - indexed for MEDLINE]Related articles

Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.

Assoumou L, Brun-Vézinet F, Cozzi-Lepri A, Kuritzkes D, Phillips A, Zolopa A, Degruttola V, Miller V, Costagliola D; Standardization and Clinical Relevance of HIV Drug Resistance Testing Project of the Forum for Collaborative HIV Research.

J Infect Dis. 2008 Aug 15;198(4):470-80.PMID: 18598191 [PubMed - indexed for MEDLINE]Related articles

AIDS-related malignancies: state of the art and therapeutic challenges.

Spano JP, Costagliola D, Katlama C, Mounier N, Oksenhendler E, Khayat D.

J Clin Oncol. 2008 Oct 10;26(29):4834-42. Epub 2008 Jun 30. Review.PMID: 18591544 [PubMed - indexed for MEDLINE]Related articles

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).

Autran B, Murphy RL, Costagliola D, Tubiana R, Clotet B, Gatell J, Staszewski S, Wincker N, Assoumou L, El-Habib R, Calvez V, Walker B, Katlama C; ORVACS Study Group.

AIDS. 2008 Jul 11;22(11):1313-22.PMID: 18580611 [PubMed - indexed for MEDLINE]Related articles

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.

Descamps D, Assoumou L, Masquelier B, Marcelin AG, Saidi S, Tamalet C, Cottalorda J, Plantier JC, Montes B, Izopet J, Peytavin G, Yerly S, Schneider V, Delaugerre C, Ferré V, Ruffault A, Pallier C, Morand-Joubert L, Chaix ML, Calvez V, Brun-Vézinet F, Costagliola D; ANRS AC-11 Resistance Study Group.

J Antimicrob Chemother. 2008 Sep;62(3):451-5. Epub 2008 Jun 13.PMID: 18552344 [PubMed - indexed for MEDLINE]Related articlesFree article

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy.

Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, Costagliola D, Mary-Krause M; FHDH-ANRS CO 4.

AIDS. 2008 Jun 19;22(10):1203-11.PMID: 18525266 [PubMed - indexed for MEDLINE]Related articles